Active Ingredient: NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
Proprietary Name: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 75MG;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209225
Product Number: 001
Approval Date: Mar 30, 2023
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information